海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
261件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)
- Alzheimer's Disease
- Austria, Finland, Sweden
- 2018-09-11
Authorised
- A study to help understand how Baricitinib in Combination with Topical Corticosteroids compares to placebo (a tablet that does not contain any active medicine) in patients with moderate to severe atopic dermatitis, also named atopic eczema
- Atopic Dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Argentina, Australia, Austria, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, Taiwan
- 2018-08-31
Not recruiting
- Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
- Dyskinesia;Levodopa-Induced Dyskinesia (LID);Parkinson's Disease (PD)
- Austria, France, Germany, Spain, United States
- 2014-10-22
Not recruiting
- Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Canada, Czech Republic, Czechia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Latvia, Netherlands, New Zealand, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2014-10-06
Not Recruiting
- A Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of Adding Mirabegron to Solifenacin in Incontinent OAB Subjects Who Have Received Solifenacin for 4 Weeks and Warrant Additional Relief for Their OAB Symptoms
- Urinary Bladder Overactive # Urinary Bladder Diseases # Urologic Diseases;N32.8 - Other specified disorders of bladder
- Armenia, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States
- 2015-04-20
Not Recruiting
- CLINICAL STUDY OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNE GLOBULIN, 20% IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
- Primary Immunodeficiency Diseases MedDRA version: 16.1 Level: PT Classification code 10064859 Term: Primary immunodeficiency syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Austria, Belgium, Germany, Hungary, Netherlands, Sweden, United Kingdom
- 2010-07-28
Not Recruiting
- A prospective outcome study on patients with profound combined immunodeficiency
- ;D83.1 - Common variable immunodeficiency with predominant immunoregulatory T-cell disorders;C91.5 - Adult T-cell leukaemia
- Austria, Canada, Czech Republic, France, Germany, Israel, Italy, Kuwait, Netherlands, Poland, Slovenia, Spain, Switzerland, United Kingdom, United States
- 2011-07-26
Not recruiting
- Safety and Tolerability of REGN668 (SAR231893) in Patients With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Australia, Germany, New Zealand
- 2011-06-09
Not Recruiting
- A clinical trial to study the safety and efficacy of the study drug when added to atorvastatin plus standard of care in subjects with Acute Coronary syndromes (ACS).
- Acute Coronary Syndromes
- Australia, Canada, Czech Republic, Georgia, Germany, Hungary, India, Italy, Lebanon, Netherlands, New Zealand, Poland, Russian Federation, Spain, Ukraine, United States of America
- 2011-05-05
Not Recruiting
- Safety and Efficacy of suvorexant (MK-4305) for the treatment of insomnia in AD subjects
- Insomnia MedDRA version: 19.0 Level: PT Classification code 10022437 Term: Insomnia System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Finland, Italy, Korea, Republic of, New Zealand, Peru, Sweden, United Kingdom, United States
- 2016-04-19